- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
22nd Century Group Inc (XXII)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.740
1.840
52 wk Range
1.740
646.500
XXII Comments
Compiled here, all relevant comments and discussions regarding the XXII stock. Please note that all comments included here have met Investing.com's Comment Guidelines.
I think we've reached the bottom. This may take a year. Look out shorty
If you drop to 1 cent I will invest another 10 k..and I know you can do it... come on 1 cent in 2 weeks
What's happening with this🤫
can you tell me? I bought it for fun
Me too ... small amount and not selling it
22nd Century reports an impressive volume of 2,810,245! This strong activity highlights increasing interest and potential for further growth in the market.
22nd Century Group, Inc. (NASDAQ: XXII) is gaining attention in the market, highlighted by a trading volume of 2,285,312 shares. As a biotechnology company focused on tobacco harm reduction and cannabis cultivation, its innovative approaches position it well within emerging sectors. Investors are keenly watching its growth potential and market strategies.
Investing in $XXII offers great returns!
$XXII is gaining traction! A top pick for growth and financial security.
$XXII shows strong potential! A reliable choice for steady investment growth.
$XXII is set for a breakout! It's time to make big moves and secure your financial future.
$XXII is set for a breakout! It's time to make big moves and secure your financial future.
$XXII is setting up perfectly! Get ready for potential gains as momentum builds.
$XXII is set for bullish momentum today, with analysts predicting impressive growth!
$XXII is gearing up for a bullish run! The current price trend is moving positively—get ready for potential gains.
Invest in $XXII for steady growth and reliability! It’s the perfect choice for long-term financial stability and progress.
22nd Century Group ($XXII) announces strategic growth initiatives for its VLN very low nicotine cigarettes, aiming to revolutionize smoking alternatives and enhance market presence.
$XXII looks bullish today! Analysts predict high growth potential, so prepare for significant gains ahead!
$XXII takes a significant step in the fight against nicotine dependence!
Don’t miss out! $XXII offers a prime opportunity to increase your holdings now!
With a market cap of $2,611,141, $XXII is ready for significant expansion!
$XXII sees impressive volume at 644,551—momentum building for future growth!
22nd Century Group, Inc.($XXII) is bolstering its Contract Manufacturing Organization (CMO) business by adding significant filtered cigar volume. This new CMO customer builds on the previously announced cigarette export business, resulting in a substantial boost to profitability. The expansion reflects the company's strategic growth initiatives and commitment to enhancing its product offerings in the tobacco industry.
22nd Century Group ($XXII) leads tobacco innovation with low-nicotine VLN® cigarettes, securing FDA's Modified Risk designation. New Moonlight brand customer in Southeast Asia could boost volumes by 30% in 2025.
22nd Century Group, Inc. ($XXII) presents an intriguing investment opportunity with a 52-week range of $0.24 to $17.06. This volatility highlights the company’s potential for growth in the emerging sectors it operates within, making it a stock worth watching for investors seeking opportunities in innovative industries.
22nd Century Group, Inc. (NASDAQ: XXII) is revolutionizing the tobacco industry with its flagship product, VLN® cigarettes, the first and only combustible cigarettes to receive the FDA's Modified Risk Tobacco Product (MRTP) designation. This milestone sets 22nd Century apart in a market increasingly focused on reducing tobacco-related harm.
22nd Century Group, Inc. ($XXII), trading at $0.3057, is revolutionizing the tobacco industry with its VLN® cigarettes, featuring 95% less nicotine and the FDA's MRTP designation for reduced-risk smoking options.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.